Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Return on Equity (2023 - 2025)

Rallybio's Return on Equity history spans 3 years, with the latest figure at 0.24% for Q3 2025.

  • For Q3 2025, Return on Equity rose 62.0% year-over-year to 0.24%; the TTM value through Sep 2025 reached 0.24%, up 62.0%, while the annual FY2024 figure was 0.66%, N/A changed from the prior year.
  • Return on Equity for Q3 2025 was 0.24% at Rallybio, up from 0.79% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.24% in Q3 2025 and bottomed at 0.86% in Q3 2024.
  • The 3-year median for Return on Equity is 0.79% (2025), against an average of 0.72%.
  • The largest annual shift saw Return on Equity dropped -21bps in 2024 before it surged 62bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 0.63% in 2023, then plummeted by -33bps to 0.84% in 2024, then surged by 72bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Return on Equity are 0.24% (Q3 2025), 0.79% (Q2 2025), and 0.8% (Q1 2025).